ホーム › 乳がん › ノースカロライナ › Winston-Salem
Winston-Salem、NCにおける乳がんの臨床試験
Winston-Salemとその周辺地域（約30マイル以内）の拠点で、乳がんに関する14件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
被験者募集中第3相
- Novant Health Oncology Specialists ( Site 0074), Winston-Salem
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
被験者募集中第3相
- Novant Health Cancer Institute, Winston-Salem
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
被験者募集中第1/2相
- Novant Health Oncology Specialists, Winston-Salem
Personalized Exercise Program for Survivors of Breast Cancer, STEPS-BC Trial
被験者募集中
- Wake Forest NCORP RB, Winston-Salem
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
被験者募集中第2相
- Comprehensive Cancer Center at Wake Forest University (CCCWFU), Winston-Salem
Distance-Based Exercise to Preserve Function and Prevent Disability
被験者募集中
- Novant Health Forsyth Medical Center, Winston-Salem
- Novant Health Cancer Institute - Kernersville, Kernersville · 10マイル先
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
被験者募集中第3相
- Novant Health Forsyth Medical Center, Winston-Salem
- Wake Forest University Health Sciences, Winston-Salem
- Novant Health Colon and Rectal Clinic, Clemmons · 9マイル先
- 他2件
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
被験者募集中第3相
- Research Site, Winston-Salem
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
被験者募集中第2相
- Atrium Health Wake Forest Baptist - Comprehensive Cancer Center, Winston-Salem
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
被験者募集中第2相
- Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
被験者募集中第3相
- Novant Health Forsyth Medical Center, Winston-Salem
- Wake Forest University Health Sciences, Winston-Salem
- Wake Forest University at Clemmons, Clemmons · 9マイル先
- 他1件
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
被験者募集中観察研究
- Wake Forest NCORP Research Base, Winston-Salem
- Wake Forest University Health Sciences, Winston-Salem
- Wake Forest University at Clemmons, Clemmons · 9マイル先
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
被験者募集中観察研究
- Atrium Health Wake Forest Baptist Medical Center, Winston-Salem
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, Winston-Salem
他の都市における乳がんの試験
- New York City, NY137件の研究
- Houston, TX127件の研究
- Boston, MA113件の研究
- Nashville, TN80件の研究
- Los Angeles, CA72件の研究
- Edison, NJ67件の研究
- St. Louis, MO65件の研究
- Durham, NC64件の研究
- Queens, NY63件の研究
- Chicago, IL59件の研究
- Philadelphia, PA57件の研究
- Dallas, TX56件の研究
Winston-Salemにおける他の研究
- がん（全種類）19件の研究
- 急性骨髄性白血病18件の研究
- 心血管疾患14件の研究
- 多発性骨髄腫14件の研究
- 非小細胞肺癌12件の研究
- COPD10件の研究
- 卵巣がん10件の研究
- 2型糖尿病9件の研究
- 骨髄異形成症候群9件の研究
- 慢性リンパ性白血病8件の研究
- 膠芽腫8件の研究
- 肺がん8件の研究
ClinicalTrials.govより、2026/10/07時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。